Alicia Silver Speaks at the American Society of Gene and Cell Therapy Policy Summit

on September 23, 2024 // 4:10-5:00pm EST

Join Alicia Silver, director of market access, cell and gene therapy, at the American Society of Gene and Cell Therapy Policy Summit on Monday, September 23, 2024, for the 2025 Payment Policy Look-Ahead Panel.

As the landscape of payment policies for cell and gene therapies evolves, understanding its impact on access has never been more important. Alicia will share her expertise on value-based arrangements, coverage, and access under employer-sponsored plans and discuss the challenges of prior authorization. She’ll also provide the latest insights on the current political landscape and what to expect in the realm of payment policy updates for 2025. Don’t miss this opportunity to gain valuable knowledge from a leading voice in healthcare policy, alongside a dynamic group of expert panelists:

  • Alicia Silver, MPP, ADVI Health
  • Pam Traxel, American Cancer Society Cancer Action Network
  • Benjamin Rome, MD, Brigham and Women’s Hospital
  • Brian Miller, MD, Johns Hopkins University School of Medicine
  • Moderator: Zachary Brennan, Endpoints News

Get in touch to meet with Alicia and Marc Samuels, CEO and president of ADVI, while you are at the event.

ADVI Team

Marc Samuels, JD, MPH

CEO and President

Alicia Silver, MPP

Director

Further Resources:

ADVI insights

Insights,

| Charles Sewell - Associate

ADVI Analysis: MACPAC October 2024 Meeting

Insights,

| Brenna Raines, MHA - Senior Director

ADVI Instant: CMS Releases 2026 Notice of Benefit and Payment Parameters Proposed Rule

Insights,

| Allison Schneider, MHA - Senior Manager

ADVI Analysis: MedPAC October 2024 Meeting

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Head of Federal and State Policy

ADVI Instant: CMS Finalizes Guidance on IPAY 2027 Negotiation and MFP Implementation for 2026/27